Nutrition interventions in congenital disorders of glycosylation

Trends Mol Med. 2022 Jun;28(6):463-481. doi: 10.1016/j.molmed.2022.04.003. Epub 2022 May 10.

Abstract

Congenital disorders of glycosylation (CDG) are a group of more than 160 inborn errors of metabolism affecting multiple pathways of protein and lipid glycosylation. Patients present with a wide range of symptoms and therapies are only available for very few subtypes. Specific nutritional treatment options for certain CDG types include oral supplementation of monosaccharide sugars, manganese, uridine, or pyridoxine. Additional management includes specific diets (i.e., complex carbohydrate or ketogenic diet), iron supplementation, and albumin infusions. We review the dietary management in CDG with a focus on two subgroups: N-linked glycosylation defects and GPI-anchor disorders.

Keywords: GPI-anchor disorder; N-linked CDG; hypoglycemia; manganese; monosaccharide therapy; pyridoxine.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Congenital Disorders of Glycosylation* / metabolism
  • Congenital Disorders of Glycosylation* / therapy
  • Glycosylation
  • Humans
  • Lipid Metabolism